Observational studyBMJ open diabetes research & care2025

Combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in heart failure patients with type 2 diabetes.

Takefumi Kishimori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.